--- title: "National Generic Pharmaceuticals - Project Revive" ocid: "ocds-h6vhtk-06e1ed" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06e1ed" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06e1ed.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06e1ed.json" source: "Find A Tender Service" current_stage: "Planning" buyer: "NHS England" published: "2026-08-20" --- # National Generic Pharmaceuticals - Project Revive Buyer: NHS England Current stage: Planning OCID: ocds-h6vhtk-06e1ed [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06e1ed) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06e1ed.json) ## Summary NHS England intends to procure national generic pharmaceutical products through Project Revive, supporting resilience and patient access in the NHS secondary-care supply chain. The programme is being delivered with the Medicines and Healthcare products Regulatory Agency and Medicines UK. It aims to reactivate dormant or unmarketed MHRA-approved marketing authorisations for critical medicines and to develop new supply routes in strategically important areas. The procurement is for goods rather than services or works and is expected to cover supply across NHS England. Specific products will be set out in the future invitation to tender. This is relevant to pharmaceutical manufacturers, marketing-authorisation holders and other suppliers able to provide generic medicines for secondary-care use, including businesses developing new routes to market. This procurement is at the planning stage: NHS England has announced its intention to tender, but has not yet issued an invitation to tender. The expected procedure is a framework agreement, with the tender issue expected on 1 October 2026. Market engagement is scheduled to run until 25 September 2026. The planned contract is expected to start on 1 April 2027 and run for 22 months to 31 January 2029, with an extension option allowing a maximum total term of 48 months, to 31 March 2031. The recorded estimated value is £1 excluding VAT and £1.20 including VAT. The procurement is above the applicable threshold and is planned as one lot, identified as suitable for small and medium-sized enterprises. The procurement is intended for suppliers with the regulatory, manufacturing and distribution capability to bring generic pharmaceuticals into secondary-care supply chains. Suppliers holding dormant or unmarketed MHRA-approved marketing authorisations may be well placed, as may businesses able to reactivate licences or establish new compliant supply routes for strategically important critical products. Existing pharmaceutical suppliers and potential new entrants are both being targeted through the engagement process. The framework structure may suit businesses seeking a route to supply multiple NHS requirements over time, while the stated suitability for small and medium-sized enterprises indicates that participation is not limited to large national manufacturers. Companies should prepare evidence of product approvals, reliable supply capacity and medicines supply-chain resilience. ## Notice National Generic Pharmaceuticals - Project Revive DCE/DSW regions - 01/04/27 to 31/01/29 (22 months) DLS/DNE regions - 01/04/27 to 31/01/29 (22 months) DLN/DNW regions - 01/04/27 to 31/01/29 (22 months) ### Planning Information NHS England is advising suppliers of an upcoming tender for the NHS National Generic Framework – Project Revive to commence on 1st April 2027 for 22 months with the option to extend to a maximum total contract length of 48 months. Project Revive was announced as an action to be delivered in the Government’s Supply Resilience Strategy, published August 2025. Project Revive is a collaboration between NHS England, MHRA and Medicines UK. This is a project aimed at reactivating dormant licences and seeking new supply routes in strategically important areas to support supply from late this year / early 2027. Project Revive will focus on secondary care supply chain resilience only. The programme aims to strengthen supply chain resilience and patient access by reactivating dormant/not marketed MHRA approved Marketing Authorisations for critical products. The purpose of this notice is to inform existing and potential new suppliers of this procurement. Useful information for suppliers can be found here: https://www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ and the current generics workplan here: https://www.england.nhs.uk/publication/generics-framework-workplan-by-product-report/ . Specific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/079388-2026 | | Notice type | UK2 - Preliminary Market Engagement Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | SME | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 20 Aug 2026 | | Submission deadline | Not specified | | Future notice date | 1 Oct 2026 | | Award date | Not specified | | Contract period | 1 Apr 2027 - 31 Jan 2029 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £1 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planning | | Lots status | Planning | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS England | | Locality | LONDON | | Postcode area | South East London | | Postcode | SE1 8UG | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI4 Inner London - East | | ITL 3 | TLI45 Lambeth | | Local authority | Lambeth | | Electoral ward | Waterloo & South Bank | | Westminster constituency | Vauxhall and Camberwell Green | | Delivery location | Not specified | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 20 Aug 2026 at 11:54 - PlanningUpdate - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/079388-2026 - 12 Aug 2026 at 08:24 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/076471-2026 ## Documents - https://www.find-tender.service.gov.uk/Notice/079388-2026 20th August 2026 - Preliminary market engagement notice on Find a Tender - https://www.find-tender.service.gov.uk/Notice/076471-2026 12th August 2026 - Preliminary market engagement notice on Find a Tender ## Notice URLs - https://www.england.nhs.uk/ - https://www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ - https://www.england.nhs.uk/publication/generics-framework-workplan-by-product-report/ - https://www.legislation.gov.uk/ukpga/2023/54/contents ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06e1ed. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06e1ed.json.